MENU
AKTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Akari Therapeutics (AKTX) Ownership - Who owns Akari Therapeutics?
Akari Therapeutics PLC is an oncology company developing next-generation antibody-drug conjugates (ADCs) designed around novel, proprietary cancer-killing toxins (payloads)... Show more
Industry: #Pharmaceuticals Major
Profile
Industry
Pharmaceuticals Major
Address
22 Boston Wharf Road
Phone
+1 929 274-7510
Employees
12
Web
https://www.akaritx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
40.37M
P/E Ratio
N/A
Total Cash
2.25M
Projected Growth
N/A
Total Debt
1M
Revenue
N/A
Risk (Beta)
0.44
Dividend Yield
N/A
Total Cash/Share
0.07
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
AKTX
Capitalization
40.4M
P/E Ratio
N/A
Risk (Beta)
0.44
Dividend Yield
N/A
Total Cash
2.25M
Total Cash/Share
0.07
Total Debt
1M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
-6.69M
P/B Ratio
1.86
Cash Flow
N/A
Earnings
-2.58
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
2.43M
Current Ratio
0.29
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-26.82M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-737.27
Shares Held By Institutions
393K
Shares Outstanding - Current
32.2M
Total Liabilities
9.43M
Total Volume MTD
N/A
Value
-1
Gain YTD
1.639
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of biopharmaceuticals
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
22 Boston Wharf Road
Phone
+1 929 274-7510
Employees
12
Web
https://www.akaritx.com